241 related articles for article (PubMed ID: 19748979)
21. Procyanidin C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation.
Nakano N; Nishiyama C; Tokura T; Nagasako-Akazome Y; Ohtake Y; Okumura K; Ogawa H
Int Arch Allergy Immunol; 2008; 147(3):213-21. PubMed ID: 18594151
[TBL] [Abstract][Full Text] [Related]
22. Peptide analogs that inhibit IgE-Fc epsilon RI alpha interactions ameliorate the development of lethal graft-versus-host disease.
Korngold R; Jameson BA; McDonnell JM; Leighton C; Sutton BJ; Gould HJ; Murphy GF
Biol Blood Marrow Transplant; 1997 Oct; 3(4):187-93. PubMed ID: 9360780
[TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
[TBL] [Abstract][Full Text] [Related]
24. Insights into immunoglobulin E receptor signaling from structurally defined ligands.
Holowka D; Sil D; Torigoe C; Baird B
Immunol Rev; 2007 Jun; 217():269-79. PubMed ID: 17498065
[TBL] [Abstract][Full Text] [Related]
25. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. IV. Delineation of target cells and mechanisms of action of SFA and EFA in inhibiting in vitro induction of FcR epsilon expression.
Marcelletti JF; Katz DH
J Immunol; 1984 Dec; 133(6):2845-51. PubMed ID: 6238087
[TBL] [Abstract][Full Text] [Related]
26. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N
Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354
[TBL] [Abstract][Full Text] [Related]
27. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
Mortara L; Frangione V; Castellani P; De Lerma Barbaro A; Accolla RS
Int Immunol; 2009 Jun; 21(6):655-65. PubMed ID: 19395374
[TBL] [Abstract][Full Text] [Related]
28. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
[TBL] [Abstract][Full Text] [Related]
29. Genetically targeted T cells eradicate established breast cancer in syngeneic mice.
Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y
Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165
[TBL] [Abstract][Full Text] [Related]
30. Whole tumor cell vaccine with irradiated S180 cells as adjuvant.
Li J; King AV; Stickel SL; Burgin KE; Zhang X; Wagner TE; Wei Y
Vaccine; 2009 Jan; 27(4):558-64. PubMed ID: 19027812
[TBL] [Abstract][Full Text] [Related]
31. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
[TBL] [Abstract][Full Text] [Related]
32. Effective anti-tumor immunity induced in mice by a two-step vaccination protocol.
Martino A; Vismara D; Cicconi R; Delpino A; Ivanyi J; Colizzi V; Cassol M; Fraziano M; Piselli P
In Vivo; 2001; 15(5):425-8. PubMed ID: 11695241
[TBL] [Abstract][Full Text] [Related]
33. Inefficient processing of mRNA for the membrane form of IgE is a genetic mechanism to limit recruitment of IgE-secreting cells.
Karnowski A; Achatz-Straussberger G; Klockenbusch C; Achatz G; Lamers MC
Eur J Immunol; 2006 Jul; 36(7):1917-25. PubMed ID: 16783846
[TBL] [Abstract][Full Text] [Related]
34. Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma.
Shadidi M; Sørensen D; Dybwad A; Furset G; Sioud M
Int J Oncol; 2008 Jan; 32(1):241-7. PubMed ID: 18097564
[TBL] [Abstract][Full Text] [Related]
35. Role of the extracellular domain of Fc epsilon RI alpha in intracellular processing and surface expression of the high affinity receptor for IgE Fc epsilon RI.
Hartman ML; Lin SY; Jouvin MH; Kinet JP
Mol Immunol; 2008 Apr; 45(8):2307-11. PubMed ID: 18179824
[TBL] [Abstract][Full Text] [Related]
36. Proximal signaling events in Fc epsilon RI-mediated mast cell activation.
Kambayashi T; Koretzky GA
J Allergy Clin Immunol; 2007 Mar; 119(3):544-52; quiz 553-4. PubMed ID: 17336609
[TBL] [Abstract][Full Text] [Related]
37. Roles of the transmembrane domain and the cytoplasmic domain of Fc epsilon RI alpha in immunoglobulin E-mediated up-regulation of surface Fc epsilon RI expression.
Okayama Y; Kagaya S; Yuki K; Arai T; Saito H
Clin Exp Allergy; 2007 Mar; 37(3):451-8. PubMed ID: 17359395
[TBL] [Abstract][Full Text] [Related]
38. The fate of IgE bound to rat basophilic leukemia cells. IV. Functional association between the receptors for IgE.
Furuichi K; Rivera J; Triche T; Isersky C
J Immunol; 1985 Mar; 134(3):1766-73. PubMed ID: 3155772
[TBL] [Abstract][Full Text] [Related]
39. IgE cross-linking or lipopolysaccharide treatment induces recruitment of Th2 cells to the lung in the absence of specific antigen.
Stephens R; Chaplin DD
J Immunol; 2002 Nov; 169(10):5468-76. PubMed ID: 12421922
[TBL] [Abstract][Full Text] [Related]
40. Differential role for CD23 splice forms in apical to basolateral transcytosis of IgE/allergen complexes.
Montagnac G; Yu LC; Bevilacqua C; Heyman M; Conrad DH; Perdue MH; Benmerah A
Traffic; 2005 Mar; 6(3):230-42. PubMed ID: 15702991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
